Back to AFFLUENT MEDICALInsider 
Company
TRUFFLE CAPITAL SAS — AFFLUENT MEDICAL
Filing 2026DD1092720Published 4 Feb 2026France public disclosures
InitialEffective
Summary
TRUFFLE CAPITAL SAS
Philippe POULETTY, Directeur Général Truffle Capital
AFFLUENT MEDICAL
Last 12 months
- Transactions
- Not available
- Total reported value
- Not available
CompanyAFFLUENT MEDICAL
ISINFR0013333077
Last 12 months
- Transactions
- Not available
- Total reported value
- Not available
Reported buys
€4,999,997.34
Reported sales
€0.00
Net buy/sell
€4,999,997.34
Other reported value
€0.00
Gross reported value
€4,999,997.34
Transactions
2
Transactions
| Execution date | Direction | Nature | Instrument | Settlement | Quantity | Unit price | Total | Venue |
|---|---|---|---|---|---|---|---|---|
| 1 Feb 2026 | BuyAcquisition / BUY | ACQUISITION | SHARE | UNKNOWN | 641,025 | €2.34 | €1,499,998.50 | XOFF |
| 1 Feb 2026 | BuyAcquisition / BUY | ACQUISITION | SHARE | UNKNOWN | 1,495,726 | €2.34 | €3,499,998.84 | XOFF |
Buy
Execution date1 Feb 2026Acquisition / BUY
ACQUISITION · SHARE · UNKNOWN · XOFF
- Quantity
- 641,025
- Unit price
- €2.34
- Total
- €1,499,998.50
Buy
Execution date1 Feb 2026Acquisition / BUY
ACQUISITION · SHARE · UNKNOWN · XOFF
- Quantity
- 1,495,726
- Unit price
- €2.34
- Total
- €3,499,998.84
Evidence
- AMF · France2026DD1092720
Corrections
Identify the affected field and a source that supports the correction. Use the private contact for rights requests; do not attach identity documents unless necessary and requested.